Tandlægeselskabet Godt Smil Hørsholm ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  3.0% 2.6% 2.7% 2.3% 3.4%  
Credit score (0-100)  57 59 60 64 54  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.1 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  8,520 8,488 7,747 8,489 8,220  
EBITDA  1,323 974 742 1,336 1,004  
EBIT  828 489 337 671 199  
Pre-tax profit (PTP)  783.8 458.0 325.8 665.8 128.3  
Net earnings  609.7 354.8 253.6 521.3 77.2  
Pre-tax profit without non-rec. items  784 458 326 666 128  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  1,839 1,422 1,117 2,983 2,237  
Shareholders equity total  1,207 1,562 1,565 1,587 1,414  
Interest-bearing liabilities  449 0.0 0.0 591 593  
Balance sheet total (assets)  4,275 3,722 2,819 3,986 3,301  

Net Debt  -168 -1,051 -637 553 529  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  8,520 8,488 7,747 8,489 8,220  
Gross profit growth  -11.6% -0.4% -8.7% 9.6% -3.2%  
Employees  11 12 11 11 11  
Employee growth %  0.0% 9.1% -8.3% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,275 3,722 2,819 3,986 3,301  
Balance sheet change%  -1.6% -12.9% -24.3% 41.4% -17.2%  
Added value  1,322.6 973.7 741.8 1,075.6 1,004.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -957 -901 -710 1,200 -1,552  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.7% 5.8% 4.3% 7.9% 2.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.5% 12.5% 10.6% 20.1% 5.7%  
ROI %  34.9% 21.5% 18.6% 33.7% 9.2%  
ROE %  67.6% 25.6% 16.2% 33.1% 5.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  29.9% 44.2% 59.1% 41.2% 44.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -12.7% -107.9% -85.9% 41.4% 52.6%  
Gearing %  37.2% 0.0% 0.0% 37.3% 41.9%  
Net interest  0 0 0 0 0  
Financing costs %  13.2% 18.2% 0.0% 5.9% 13.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.6 1.1 1.7 0.3 0.4  
Current Ratio  0.8 1.3 1.9 0.5 0.7  
Cash and cash equivalent  617.0 1,050.6 637.2 37.9 64.1  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -439.7 475.8 760.4 -900.3 -479.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  120 81 67 98 91  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  120 81 67 121 91  
EBIT / employee  75 41 31 61 18  
Net earnings / employee  55 30 23 47 7